Thompson AJ - Search Results

1

Managing patients with late-onset neutropenia during treatment with ocrelizumab.

Wright SL, Thompson AJ. Wright SL, et al. Among authors: thompson aj. Mult Scler. 2024 Jan;30(1):134. doi: 10.1177/13524585231206219. Epub 2023 Oct 27. Mult Scler. 2024. PMID: 37888826 No abstract available.

2

Paradigm shifts: Early initiation of high-efficacy disease-modifying treatment in multiple sclerosis.

Hartung HP, Meuth SG, Thompson AJ. Hartung HP, et al. Among authors: thompson aj. Mult Scler. 2021 Sep;27(10):1473-1476. doi: 10.1177/13524585211033190. Mult Scler. 2021. PMID: 34472985 No abstract available.

3

Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community.

Thompson AJ, Moccia M, Amato MP, Calabresi PA, Finlayson M, Hawton A, Lublin FD, Marrie RA, Montalban X, Panzara M, Sormani MP, Strum J, Vickrey BG, Coetzee T. Thompson AJ, et al. Mult Scler. 2023 Oct;29(11-12):1363-1372. doi: 10.1177/13524585231196786. Epub 2023 Sep 11. Mult Scler. 2023. PMID: 37691493 Free PMC article.

4

Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis.

Cawley N, Tur C, Prados F, Plantone D, Kearney H, Abdel-Aziz K, Ourselin S, Wheeler-Kingshott CAG, Miller DH, Thompson AJ, Ciccarelli O. Cawley N, et al. Among authors: thompson aj. Mult Scler. 2018 Jun;24(7):932-941. doi: 10.1177/1352458517709954. Epub 2017 May 18. Mult Scler. 2018. PMID: 28516804

5

New insights into the burden and costs of multiple sclerosis in Europe: Results for the United Kingdom.

Thompson A, Kobelt G, Berg J, Capsa D, Eriksson J, Miller D; European Multiple Sclerosis Platform. Thompson A, et al. Mult Scler. 2017 Aug;23(2_suppl):204-216. doi: 10.1177/1352458517708687. Mult Scler. 2017. PMID: 28643587

6

Advancing trial design in progressive multiple sclerosis.

Miller DH, Thompson AJ. Miller DH, et al. Among authors: thompson aj. Mult Scler. 2017 Oct;23(12):1571-1572. doi: 10.1177/1352458517729767. Mult Scler. 2017. PMID: 29041869 No abstract available.

7

MSJ 2019 - Editorial comment.

Thompson AJ, Antel J, Carroll WB, Geurts J. Thompson AJ, et al. Mult Scler. 2019 Jan;25(1):4-5. doi: 10.1177/1352458518819096. Mult Scler. 2019. PMID: 30799696 No abstract available.

8

Clinical relevance of cortical network dynamics in early primary progressive MS.

Tur C, Kanber B, Eshaghi A, Altmann DR, Khaleeli Z, Prados F, Ourselin S, Thompson AJ, Gandini Wheeler-Kingshott CA, Toosy AT, Ciccarelli O. Tur C, et al. Among authors: thompson aj. Mult Scler. 2020 Apr;26(4):442-456. doi: 10.1177/1352458519831400. Epub 2019 Feb 25. Mult Scler. 2020. PMID: 30799709

9

Improved performance of the 2017 McDonald criteria for diagnosis of multiple sclerosis in children in a real-life cohort.

Hacohen Y, Brownlee W, Mankad K, Chong WK', Thompson A, Lim M, Wassmer E, Hemingway C, Barkhof F, Ciccarelli O. Hacohen Y, et al. Mult Scler. 2020 Oct;26(11):1372-1380. doi: 10.1177/1352458519863781. Epub 2019 Jul 18. Mult Scler. 2020. PMID: 31317829

10

Ongoing microstructural changes in the cervical cord underpin disability progression in early primary progressive multiple sclerosis.

Cortese R, Tur C, Prados F, Schneider T, Kanber B, Moccia M, Wheeler-Kingshott CAG, Thompson AJ, Barkhof F, Ciccarelli O. Cortese R, et al. Among authors: thompson aj. Mult Scler. 2021 Jan;27(1):28-38. doi: 10.1177/1352458519900971. Epub 2020 Jan 21. Mult Scler. 2021. PMID: 31961242

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,116 results

Search Page